Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score

Journal of Gastroenterology

Volumn 40, Issue 10, 2005, Pages 972-979

  Kubo, Shoji ^a   Tanaka, Hiromu ^a   Shuto, Taichi ^a   Takemura, Shigekazu ^a   Yamamoto, Takatsugu ^a   Uenishi, Takahiro ^a   Tanaka, Shogo ^a   Hai, Seikan ^a   Yamamoto, Satoshi ^a   Ichikawa, Tsuyoshi ^a   Kodai, Shintaro ^a   Hirohashi, Kazuhiro ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatitis virus; Hepatocellular carcinoma; Japan integrated staging score; Liver resection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HISTOPATHOLOGY; HUMAN; JAPAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 27944488379     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-005-1681-1     Document Type: Article

References (43)

1. The Cancer of the Liver Italian Program (CLIP) Investigators 1998 A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients Hepatology 28 751-5
2. CLIP Group (Cancer of the Liver Italian Program) 1998 Tamoxifen in treatment of hepatocellular carcinoma: A randomised controlled trial Lancet 352 17-20
3. The Cancer of the Liver Italian Program (CLIP) Investigators 2000 Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma Hepatology 31 840-5
4. JM Llovet J Bruix 2000 BCLC group. Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma: Correspondence Hepatology 32 679-80 10.1053/jhep.2000.16475 10991637
5. F Farinati M Rinaldi S Gianni R Naccarato 2000 How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system Cancer 89 2266-73 10.1002/ 1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0 11147597
6. S Ueno G Tanabe K Sako T Hiwaki H Hokotate Y Fukukura 2001 Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients Hepatology 23 529-34 10.1053/jhep.2001.27219
7. I Levy M Sherman The Liver Cancer Study Group of the University of Toronto 2002 Staging of hepatocellular carcinoma: Assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto Gut 50 881-5 10.1136/gut.50.6.881 12010894
8. C Rabe M Lenz V Schmitz T Pilz R Fimmers T Sauerbruch et al. 2003 An independent evaluation of modern prognostic scores in a central European cohort of 120 patients with hepatocellular carcinoma Eur J Gastroenterol Hepatol 15 1305-15 10.1097/00042737-200312000-00009 14624154
9. E Giannini D Risso F Botta P Romagnoli F Malfatti A Fumagalli et al. 2004 Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: A single-centre comparison among four different staging systems J Intern Med 225 399-408 10.1046/j.1365-2796.2003.01284.x
10. S Wildi BC Pestalozzi L McCormack PA Clavien 2004 Critical evaluation of the different staging systems for hepatocellular carcinoma Br J Surg 91 400-8 10.1002/bjs.4554 15048738
11. M Kudo H Chung Y Osaki 2003 Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan integrated staging score (JIS score) J Gastroenterol 38 207-15 10.1007/s005350300038 12673442
12. Liver Cancer Study Group of Japan 2000 The general rules for the clinical and pathological study of primary liver cancer (in Japanese) 4th ed. Kanehara Tokyo 19
13. M Kudo H Chung S Haji Y Osaki H Oka T Seki et al. 2004 Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score Hepatology 40 1396-405 10.1002/ hep.20486 15565571
14. Y Shiratori S Shiina M Imamura M Kato F Kanai T Okudaira et al. 1995 Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan Hepatology 22 1027-33 10.1016/ 0270-9139(95)90605-3 7557847
15. S Miyagawa S Kawasaki M Makuuchi 1996 Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C Hepatology 24 307-10 8690397
16. H Tanizaki M Ryu T Kinoshita N Kawano M Konishi A Cho et al. 1997 Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma Jpn J Clin Oncol 27 67-70 10.1093/jjco/27.2.67 9152792
17. N Yamanaka T Tanaka W Tanaka J Yamanaka C Yasui N Kuroda et al. 1997 Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma Cancer 79 1509-15 10.1002/ (SICI)1097-0142(19970415)79:8<1509::AID-CNCR10>3.0.CO;2-1 9118031
18. T Shuto K Hirohashi S Kubo T Taukamoto T Yamamoto K Wakasa et al. 1998 Differences of resected hepatocellular carcinoma with hepatitis B or C virus Hepatogastroenterology 45 1722-5 9840135
19. S Roayaie M Ben Haim S Emre TM Fishbein PA Sheiner CM Miller et al. 2000 Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A western experience Ann Surg Oncol 7 764-70 10.1007/s10434-000-0764-8 11129425
20. N Iizuka M Oka H Yamada-Okabe N Mori T Tamesa T Okada et al. 2002 Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method Cancer Res 62 3939-44 12124323
21. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver: A study of 100 cases among 48900 necropsies Cancer 7 462-503 13160935
22. Liver Cancer Study Group of Japan 1997 Classification of ordinary liver cancer First English ed. Kanehara Tokyo
23. VJ Desmet M Gerber JH Hoofnagle M Manns PJ Scheuer 1994 Classicification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1513-20 10.1016/0270-9139(94)90250-X 8188183
24. T Shuto H Kinoshita K Hirohashi S Kubo H Tanaka T Tsukamoto et al. 1996 Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma Hepatogastroenterology 43 932-7 8884316
25. Liver Cancer 1990 Study Group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment Ann Surg 221 277-87
26. T Kumada S Nakano I Takeda K Sugiyama T Osada S Kiriyama et al. 1997 Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma Hepatology 25 87-92 8985270
27. M Sakon K Umeshita H Nagano H Eguchi S Kishimoto A Miyamoto et al. 2000 Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves Arch Surg 135 1456-9 10.1001/ archsurg.135.12.1456 11115352
28. K Ikeda S Saitoh I Koida Y Arase A Tsubota K Chayama et al. 1993 A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis Hepatology 18 47-53 10.1016/0270-9139(93)90505-H 7686879
29. S Takano O Yokosuka F Imazeki M Tagawa M Omata 1995 Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients Hepatology 21 650-5 10.1016/0270-9139(95)90513-8 7875662
30. S Kubo S Nishiguchi K Hirohashi T Shuto T Kuroki S Minamitani et al. 1998 Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis Jpn J Cancer Res 89 419-26 9617348
31. S Kubo S Nishiguchi T Shuto H Tanaka T Tsukamoto K Hirohashi et al. 1999 Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma Jpn J Cancer Res 90 162-70 10189886
32. S Kubo H Kinoshita K Hirohashi H Tanaka T Tsukamoto H Hamba et al. 1999 Patterns and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma; a special reference to multicentric carcinogenesis after operation Hepatogastroenterology 46 3212-5 10626188
33. S Kubo K Hirohashi H Tanaka T Tsukamoto T Shuto T Yamamoto et al. 2000 Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma Cancer 88 1016-24 10.1002/ (SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V 10699889
34. S Kubo K Hirohashi H Tanaka T Tsukamoto T Shuto I Higaki et al. 2001 Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma Dig Surg 18 26-33 10.1159/000050093 11244256
35. S Ko Y Nakajima H Kanehiro M Hisanaga Y Aomatsu T Kin et al. 1996 Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy: Result of multivariate analysis Ann Surg 224 591-5 10.1097/ 00000658-199611000-00001 8916872
36. K Shirabe K Takenaka A Taketomi N Kawahara K Yamamoto M Shimada et al. 1996 Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma Cancer 77 1050-5 10.1002/ (SICI)1097-0142(19960315)77:6<1050::AID-CNCR7>3.0.CO;2-L 8635122
37. K Tarao A Takemiya S Tamai Y Sugimasa S Ohkawa M Akaike et al. 1997 Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC Cancer 79 688-94 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A 9024706
38. S Kubo T Yamamoto T Ikebe T Shuto K Hirohashi H Tanaka et al. 1999 Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C Jpn J Cancer Res 90 1076-80 10595735
39. H Yoshida Y Shiratori M Moriyama Y Arakawa T Ide M Sata et al. 1999 Interferon therapy reduces the risk of hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan Ann Intern Med 131 174-81 10428733
40. S Kubo K Hirohashi H Tanaka T Tsukamoto T Shuto T Ikebe et al. 2000 Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma World J Surg 24 1559-65 10.1007/s002680010277 11193723
41. N Yamanaka M Takada T Tanaka J Yamanaka C Yasui T Ando et al. 2000 Viral serostatus and coexisting inflammatory activity affect metachronous carcinogenesis after hepatectomy for hepatocellular carcinoma. A further report J Gastroenterol 35 206-13 10.1007/s005350050332 10755690
42. MM Bilimoria GY Lauwers DA Doherty DM Nagorney J Belghiti KA Do et al. 2001 Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma Arch Surg 136 528-35 10.1001/archsurg.136.5.528 11343543
43. S Kubo H Tanaka T Shuto S Takemura T Yamamoto T Uenishi et al. 2004 Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C Hepatol Res 30 221-5 10.1016/j.hepres.2004.10.005 15589130